About this FactMed analysis covering adverse side effect reports of ACETASOL patients who developed HAEMOPTYSIS.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 8 individuals taking ACETASOL reported HAEMOPTYSIS to the FDA. A total of 32 ACETASOL drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between ACETASOL and HAEMOPTYSIS. In doing so, we compare ACETASOL with other drugs that cause HAEMOPTYSIS, to help you evaluate whether or not ACETASOL causes HAEMOPTYSIS. Likewise, this page shows the most highly-reported side effects of ACETASOL, so you can see if HAEMOPTYSIS ranks among ACETASOL's most well-known side effects.
Summary Statistics
Reports of ACETASOL causing HAEMOPTYSIS: 8
Reports of any side effect of ACETASOL : 32
Percentage of ACETASOL patients where HAEMOPTYSIS is a reported side effect: 25.0000%

FDA reports of any drug causing HAEMOPTYSIS : 8968
Average percentage for all medicated patients where HAEMOPTYSIS is reported as a complication: 0.0562%

Physician opinion on ACETASOL as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing ACETASOL:
EAR INFECTION ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with HAEMOPTYSIS:

ASPIRIN (1072 patients)
HEPARIN SODIUM INJECTION (772 patients)
COUMADIN (504 patients)
WARFARIN SODIUM (446 patients)
PREDNISONE (440 patients)
ZOMETA (432 patients)
LASIX (427 patients)
SIMVASTATIN (393 patients)
CARBOPLATIN (377 patients)
PLAVIX (372 patients)
VIOXX (364 patients)
OMEPRAZOLE (352 patients)
FOSAMAX (345 patients)
LIPITOR (333 patients)
ALBUTEROL (332 patients)
NEXIUM (318 patients)
LISINOPRIL (316 patients)
PREDNISOLONE (315 patients)
FUROSEMIDE (314 patients)
HUMIRA (287 patients)
DEXAMETHASONE (286 patients)
SPIRIVA (273 patients)
ACETAMINOPHEN (272 patients)
DIGOXIN (272 patients)
AVASTIN (270 patients)
AREDIA (269 patients)
CISPLATIN (250 patients)
METHOTREXATE (244 patients)
ADVAIR DISKUS 100/50 (243 patients)
FOLIC ACID (243 patients)
PRILOSEC (241 patients)
REVLIMID (236 patients)
PRADAXA (234 patients)
VICODIN (230 patients)
ALLOPURINOL (227 patients)
LEVAQUIN (227 patients)
OXYCONTIN (222 patients)
POTASSIUM CHLORIDE (217 patients)
ATENOLOL (216 patients)
NEURONTIN (213 patients)
HYDROCHLOROTHIAZIDE (207 patients)
PROTONIX (199 patients)
IBUPROFEN (194 patients)
AMBIEN (190 patients)
LEVOTHYROXINE SODIUM (190 patients)
CELEBREX (189 patients)
SYNTHROID (189 patients)
TARCEVA (185 patients)
AMLODIPINE (184 patients)
TRACLEER (184 patients)
ZOCOR (183 patients)
NORVASC (182 patients)
HEPARIN (178 patients)
AMOXICILLIN (178 patients)
NEXAVAR (175 patients)
TOPROL-XL (174 patients)
TAXOTERE (170 patients)
DECADRON (169 patients)
LORTAB (169 patients)
MORPHINE (166 patients)
METOPROLOL TARTRATE (165 patients)
XANAX (163 patients)
PERCOCET (160 patients)
ZOLOFT (157 patients)
ZOFRAN (155 patients)
PREVACID (154 patients)
OXYCODONE HCL (152 patients)
LYRICA (148 patients)
VITAMIN D (145 patients)
PREDNISONE TAB (144 patients)
RIBAVIRIN (141 patients)
PACLITAXEL (139 patients)
NITROGLYCERIN (138 patients)
LANSOPRAZOLE (138 patients)
ATROVENT (136 patients)
DURAGESIC-100 (136 patients)
SPIRONOLACTONE (136 patients)
LORAZEPAM (135 patients)
METFORMIN HCL (132 patients)
VITAMIN B-12 (131 patients)
SINGULAIR (131 patients)
TAXOL (128 patients)
LEXAPRO (126 patients)
PEGASYS (125 patients)
SUTENT (125 patients)
NUVARING (124 patients)
MULTI-VITAMINS (124 patients)
ENBREL (123 patients)
LOVENOX (123 patients)
CELEXA (122 patients)
FLOMAX (120 patients)
ATIVAN (119 patients)
VELCADE (119 patients)
CALCIUM (117 patients)
ALDACTONE (116 patients)
REMICADE (116 patients)
ZITHROMAX (116 patients)
BEVACIZUMAB (116 patients)
RANITIDINE (116 patients)
ZYPREXA (114 patients)
CYCLOPHOSPHAMIDE (112 patients)
INSULIN (111 patients)
FLUOROURACIL (111 patients)
YASMIN (111 patients)
YAZ (110 patients)
OXYGEN (108 patients)
ZANTAC (106 patients)
COREG (105 patients)
MUCINEX (105 patients)
DILAUDID (104 patients)
CYTARABINE (103 patients)
GLEEVEC (103 patients)
DOCETAXEL (102 patients)
VANCOMYCIN (102 patients)
LANTUS (102 patients)
REGLAN (102 patients)
ETOPOSIDE (101 patients)
FERROUS SULFATE TAB (101 patients)
CRESTOR (101 patients)
CYMBALTA (100 patients)
WARFARIN (100 patients)
COMPAZINE (100 patients)
IRESSA (99 patients)
SEROQUEL (99 patients)
FORTEO (99 patients)
FLUCONAZOLE (98 patients)
FENTANYL (98 patients)
PROZAC (97 patients)
PANTOPRAZOLE (97 patients)
CLINDAMYCIN (96 patients)
AVELOX (96 patients)
SANDOSTATIN LAR (95 patients)
ACETYLSALICYLIC ACID SRT (95 patients)
METOPROLOL (95 patients)
CHEMOTHERAPEUTICS NOS (94 patients)
DIOVAN (94 patients)
COLACE (94 patients)
THALIDOMIDE (94 patients)
PAXIL (94 patients)
FLEXERIL (94 patients)
CLONAZEPAM (93 patients)
CHANTIX (92 patients)
TYLENOL (92 patients)
MULTI-VITAMIN (92 patients)
BENADRYL (91 patients)
MS CONTIN (91 patients)
ALIMTA (90 patients)
RADIATION THERAPY (90 patients)
GLIPIZIDE (89 patients)
GABAPENTIN (89 patients)
MORPHINE SULFATE (88 patients)
PLACEBO (87 patients)
COMBIVENT (86 patients)
AZITHROMYCIN (86 patients)
CETUXIMAB (85 patients)
CARVEDILOL (85 patients)
PEMETREXED (84 patients)
ARANESP (84 patients)
PEG-INTRON (83 patients)
HEPARIN SODIUM (82 patients)
METOPROLOL SUCCINATE (81 patients)
WELLBUTRIN (81 patients)
CITALOPRAM HYDROBROMIDE (80 patients)
TRAZODONE HCL (80 patients)
PREMARIN (80 patients)
ACYCLOVIR (80 patients)
AMITRIPTYLINE HCL (79 patients)
AMIODARONE HCL (79 patients)
LACTULOSE (77 patients)
GLUCOPHAGE (77 patients)
ENALAPRIL MALEATE (77 patients)
ASCORBIC ACID (76 patients)
KEFLEX (76 patients)
GEMCITABINE (76 patients)
FLOLAN (76 patients)
METHYLPREDNISOLONE (75 patients)
FAMOTIDINE (75 patients)
KLONOPIN (75 patients)
COPEGUS (75 patients)
METOCLOPRAMIDE (75 patients)
ROCEPHIN (75 patients)
MAGNESIUM OXIDE (74 patients)
LEVOFLOXACIN (73 patients)
AUGMENTIN '125' (73 patients)
DIAZEPAM (72 patients)
LOPRESSOR (71 patients)
GLYBURIDE (71 patients)
NEORAL (71 patients)
ZYRTEC (71 patients)
ALPRAZOLAM (71 patients)
LETAIRIS (70 patients)
PROSCAR (70 patients)
ZOLPIDEM (70 patients)
ICL670A ICL+DISTAB (69 patients)
VITAMIN E (69 patients)
SOLU-MEDROL (69 patients)
SYMBICORT (68 patients)
EFFEXOR (68 patients)
ERLOTINIB HYDROCHLORIDE (68 patients)
CIPROFLOXACIN (67 patients)
DOXYCYCLINE (67 patients)
TRAMADOL HCL (67 patients)
AVONEX (66 patients)
CLARITHROMYCIN (65 patients)
VENTOLIN (64 patients)
VALIUM (64 patients)
PROCHLORPERAZINE (64 patients)
ENOXAPARIN SODIUM (64 patients)
HYDROCODONE (64 patients)
TORSEMIDE (63 patients)
Most common side effects for patients taking ACETASOL:
ANTIPHOSPHOLIPID SYNDROME (20 patients)
PERICARDITIS (20 patients)
PLEURISY (20 patients)
PULMONARY EMBOLISM (20 patients)
SYSTEMIC LUPUS ERYTHEMATOSUS (20 patients)
COLLAPSE OF LUNG (13 patients)
FALL (9 patients)
EMPHYSEMA (8 patients)
HAEMOPTYSIS (8 patients)
HEPATIC STEATOSIS (8 patients)
HEPATOMEGALY (8 patients)
POST PROCEDURAL COMPLICATION (8 patients)
RED BLOOD CELL COUNT DECREASED (8 patients)
RESPIRATORY DISTRESS (8 patients)
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED (4 patients)
ANTINUCLEAR ANTIBODY POSITIVE (4 patients)
ANTIPHOSPHOLIPID ANTIBODIES POSITIVE (4 patients)
BLOOD ALKALINE PHOSPHATASE INCREASED (4 patients)
BLOOD PRESSURE DECREASED (4 patients)
BLOOD UREA DECREASED (4 patients)
FLUID OVERLOAD (4 patients)
HEART RATE INCREASED (4 patients)
MYOCARDIAL INFARCTION (4 patients)
PROCEDURAL COMPLICATION (4 patients)
BLOOD CHOLESTEROL INCREASED (3 patients)
CEREBROVASCULAR ACCIDENT (3 patients)
COUGH (3 patients)
DEPRESSION (3 patients)
DYSPEPSIA (3 patients)
URINARY TRACT INFECTION (3 patients)
ACUTE MYOCARDIAL INFARCTION (2 patients)
ASTHENIA (2 patients)
CARDIAC FAILURE CONGESTIVE (2 patients)
CYSTITIS (2 patients)
DEHYDRATION (2 patients)
DIABETES MELLITUS NON-INSULIN-DEPENDENT (2 patients)
DISEASE RECURRENCE (2 patients)
DIZZINESS (2 patients)
ERYTHEMA (2 patients)
GASTROOESOPHAGEAL REFLUX DISEASE (2 patients)
HEPATIC CIRRHOSIS (2 patients)
HICCUPS (2 patients)
HYPOTHYROIDISM (2 patients)
INFLUENZA (2 patients)
ISCHAEMIC STROKE (2 patients)
NAUSEA (2 patients)
SLEEP DISORDER (2 patients)
STAPHYLOCOCCAL INFECTION (2 patients)
VISUAL DISTURBANCE (2 patients)
VOMITING (2 patients)
WEIGHT DECREASED (2 patients)
WEIGHT INCREASED (2 patients)
ABDOMINAL SEPSIS (1 patients)
ACUTE ABDOMEN (1 patients)
ACUTE RESPIRATORY FAILURE (1 patients)
AFFECT LABILITY (1 patients)
ANXIETY (1 patients)
AORTIC VALVE SCLEROSIS (1 patients)
ARTERIOSCLEROSIS (1 patients)
ARTERIOVENOUS FISTULA OPERATION (1 patients)
ASCITES (1 patients)
ATRIOVENTRICULAR BLOCK FIRST DEGREE (1 patients)
BACK PAIN (1 patients)
BACTERIAL INFECTION (1 patients)
BALANCE DISORDER (1 patients)
BLINDNESS (1 patients)
BLOOD PRESSURE INCREASED (1 patients)
BLOOD TRIGLYCERIDES INCREASED (1 patients)
BRONCHIAL OBSTRUCTION (1 patients)
BUNDLE BRANCH BLOCK LEFT (1 patients)
CARDIOVASCULAR DISORDER (1 patients)
CAROTID ARTERY DISEASE (1 patients)
CEREBRAL ATROPHY (1 patients)
CEREBRAL INFARCTION (1 patients)
CERUMEN IMPACTION (1 patients)
CHEYNE-STOKES RESPIRATION (1 patients)
CONSTIPATION (1 patients)
CONVULSION (1 patients)
CORONARY ARTERY DISEASE (1 patients)
CORONARY ARTERY STENOSIS (1 patients)
DEAFNESS NEUROSENSORY (1 patients)
DEEP VEIN THROMBOSIS (1 patients)
DERMATITIS (1 patients)
DIABETES MELLITUS (1 patients)
DIFFICULTY IN WALKING (1 patients)
DISORIENTATION (1 patients)
DISTURBANCE IN ATTENTION (1 patients)
DIVERTICULUM DUODENAL (1 patients)
DRUG INEFFECTIVE (1 patients)
DYSPNOEA EXERTIONAL (1 patients)
DYSSTASIA (1 patients)
EAR INFECTION (1 patients)
EYE INFECTION (1 patients)
EYE IRRITATION (1 patients)
FEELING HOT (1 patients)
FOOT FRACTURE (1 patients)
GALLBLADDER DISORDER (1 patients)
GASTRITIS (1 patients)
GRAND MAL CONVULSION (1 patients)
GROIN INFECTION (1 patients)
HERNIA (1 patients)
HYPERSENSITIVITY (1 patients)
INFECTION (1 patients)
INSOMNIA (1 patients)
INTESTINAL INFARCTION (1 patients)
IRRITABLE BOWEL SYNDROME (1 patients)
LIBIDO DECREASED (1 patients)
MENTAL STATUS CHANGES (1 patients)
MITRAL VALVE INCOMPETENCE (1 patients)
MITRAL VALVE SCLEROSIS (1 patients)
MYALGIA (1 patients)
NASAL CONGESTION (1 patients)
NEPHROLITHIASIS (1 patients)
NON-CARDIAC CHEST PAIN (1 patients)
OEDEMA (1 patients)
OSTEOARTHRITIS (1 patients)
OSTEOPENIA (1 patients)
PARATHYROID DISORDER (1 patients)
PERITONITIS (1 patients)
POLYARTHRITIS (1 patients)
PROCTITIS (1 patients)
PULMONARY HYPERTENSION (1 patients)
RASH (1 patients)
RESPIRATORY FAILURE (1 patients)
RHINITIS ALLERGIC (1 patients)
ROAD TRAFFIC ACCIDENT (1 patients)
SEPTIC SHOCK (1 patients)
SINUSITIS (1 patients)
SKIN INFECTION (1 patients)
SLEEP APNOEA SYNDROME (1 patients)
SOMNOLENCE (1 patients)
STENT OCCLUSION (1 patients)
TRANSIENT ISCHAEMIC ATTACK (1 patients)
TRICUSPID VALVE INCOMPETENCE (1 patients)
VASCULAR PSEUDOANEURYSM (1 patients)
VERTIGO (1 patients)
WOUND INFECTION PSEUDOMONAS (1 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for ACETASOL


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about HAEMOPTYSIS and ACETASOL, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking ACETASOL, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in ACETASOL. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for ACETASOL experts. If you are a healthcare provider experienced in prescribing ACETASOL, please register here.
giCould not connect: